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Introduction 
Up  to  20%  of  young  couples  are  suffering  from 
infertility  problem.  One  of  the  major  causes  of 
infertility is the use of anticancer drugs.
1 The effects of 
anticancer drugs are  based on  their antimitotic  action 
such as spermatogenic cells. 
Spermatogenesis  is  influenced  by  radiotherapy  and 
cancer  cytotoxic  drugs.
2-5  Cisplatin  is  used  for 
treatment of various malignancies including cancer  of 
testis,  ovary,  lung,  bladder  and  Hodgkin  and  non-
Hodgkin  lymphoma.
6-8  The  previous  studies  showed 
the  side  effects  of  chemotherapeutic  drugs  such  as 
azoospermia  after  treatment.
3,9  The  side  effects  of 
Cisplatin  on  the  spermatogenesis  when  used  as 
anticancer drugs are known.
10 In comparison to normal 
tissue,  tumors  are  characterized  by  uncontrolled 
division.  The  process  of  cell  division-  normal  or 
cancerous cell- is through the cell cycle. The cell cycle 
goes  from  the  resting  phase,  through  active  growing 
phases  and  then  to  mitosis  (division).  The  ability  of 
chemotherapy to kill cancer cells depends on its ability 
to  halt  cell  division.  Therefore  chemotherapy  is  most 
effective  at  killing  cells  that  are  rapidly  dividing. 
Unfortunately,  chemotherapeutic  agents  can  not 
differentiate  between  the  cancerous  and  the  normal 
cells.  It  has  been  shown  that  apoptosis  is  one  of  the 
mechanisms  in  cell  destruction  following 
chemotherapy.
10-14 Some agents could increase the rate 
of germ cell apoptosis in testis such as genes factors, 
testicular ischemia, heat stress, exposure to irradiation 
and  toxic  substances.
5,10-15  On  the  other  hand,  it  is 
known  that  spermatogenesis  is  effected  by  FSH,  LH 
and  testosterone  and  suppression  of  them  could 
suppress spermatogenesis. Thus it is logical to conclude 
that suppression of gonadotropins during chemotherapy 
would  protect  spermatogenesis  by  inhibition  of  their 
proliferation.  For  the  first  time,  Glode et  al.  showed 
that  disturbance  of  hypothalamo  –  hypopheseal  axis 
and  reduction  the  FSH  and  LH  secretion  during 
chemotherapy  resulted  in  promotion  of 
spermatogenesis  after  chemotherapy.
16  There  are 
different  methods  for  inhibition  of  hypothalamo  – 
hypopheseal  axis  including  usage  of  agonist  and 
antagonist of GnRH.
16-19 As mentioned earlier, cisplatin 
is  commonly  used  for  treatment  of  different 
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Purpose: Anti cancer drugs is one of the most important chemotherapeutic factors which 
can influence spermatogenesis process and germinal epithelium. Since dividing cells are 
mainly affected by anticancer drugs, the aim of the present study is to investigate the 
preventive effect of GnRH antagonist on spermatogenic defect produced by anticancer 
drugs.  Methods:  In  the  present  study  thirty  adult  male  mice  aging  6-8  weeks  were 
divided into 3 groups as: Control, Experimental 1 and Experimental 2. Experimental 1 
group received Cisplatin for 5 days as 2.5 mg/kg intraperitoneally and Experimental 2 
group  received  0.25  mg/kg  cetrorelix  (GnRH  antagonist)  one  week  before  cisplatin 
treatment and continued for 3 weeks. The mice in all groups were sacrificed 35 days 
after the last injection and testis specimens were fixed in boueins, formaldehyde fixative 
and 2.5% Glutaraldehide then prepared for light and electron microscopic examination. 
Results: Light microscopy (LM) study showed that the number of spermatogonial cells, 
thickness  of  germinal  epithelium,  was  decreased  in  Experimental  1group.  Electron 
microscopy  revealed  that  in  this  group  several  intercellular  spaces  appeared  between 
spermatogenic cells and secretory granules in interstitial cells was increased. There were 
several vacuolated mitochondria and destroyed organelles in spermatogonial cells but in 
Experimental 2 group condition was similar to control group. Conclusion: These results 
indicate that the cetrorelix administration before cancer treatment may protect germinal 
epithelium against side effects of cisplatin. 
  
 324  | 
Mohammadnejad et al. 
Advanced Pharmaceutical Bulletin, 2013, 3(2), 323-328  Copyright © 2013 by Tabriz University of Medical Sciences 
malignancies and its effect on spermatogenesis is well 
studied
6-8  but  there  is  not  enough  study  about 
ultrastructural alterations. Since ultrastructural studies 
are useful  for  evaluation of  intercellular  junction  and 
status of organelles could help in understanding of the 
mechanism of action of cisplatin therefore we decided 
to  study  the  ultrastructural  changes  induced  by 
cisplatin. Similarly the inhibitory effect of  Cetrorelix, 
as  an  antagonist  of  GnRH,  on  spermatogenesis 
following  treatment  with  cisplatin  has  poorly  been 
studied and there is no ultrastructural study about this 
matter.  Therefore,  the  aim  of  present  study  is  1)  to 
investigate  the  action  mechanism  of  cisplatin  on 
germinal epithelium based on morphological criteria. 2) 
To  investigate  the  protective  effect  of  cetrorelix  on 
spermatogenesis  following  treatment  with  cisplatin, 
using ultrastructural criteria.  
 
Materials and Methods 
Male balb/c mice aging 6-8 weeks (n = 30), were cared 
for  according  to  the  Guide  for the  Care  and  Use  of 
Laboratory  Animals  of  Tabriz  University  of  Medical 
Sciences and housed under controlled conditions (12-h 
light/12-h dark) with free access to water and food. The 
mice were divided into three groups equally as follows: 
control  (n=10),  experimental  1  (n=10)  and 
experimental 2 (n=10). In experimental 1 group, mice 
received  2.5  mg/kg  daily  cisplatin  intraperitonally  for 
five days. In experimental 2 group the mice in addition 
to  cisplatin  received  cetrorelix  subcutaneously  0.25 
mg/kg  3  times  a  week.  Cetrorelix  application  started 
first week prior to cisplatin treatment and continued for 
three weeks. Since spermatogenic cycle in mice is 35 
days, the  mice  in  all  three  groups  were  sacrificed by 
cervical dislocation 35 days after last injection. Then, 
testes  were  removed  from  the  abdominal  cavity  and 
separated  from  the  epididymis  carefully  by  using  a 
surgical blade. Right testis was fixed in Bouins fixative 
for 48 h for quantitative studies and then processed for 
light  microscopy.  The  paraffin  sections  were  stained 
with H & E and examined with light microscope. For 
quantitative  analyses,  we  used  Motic  Image  plus  20 
Software.  20  microscopic  fields,  in  seminiferous 
tubules from each mouse, the number of spermatogonia 
was counted and thickness of germinal epithelium was 
determined.
4  The  obtained  data  were  analysed  with 
Kruskal-Wallis test by using SPSS.13 software.  
The specimens from the left testis were fixed in 2.5% 
Glutaraldehyde  (Pro.  Sci.  Tech.  Au)  for  12  h  and 
washed  with  0.2  M  phosphate  buffer  and  post  fixed 
with 2% osmium tetroxide (TAAB, UK) for 2 h. After 
dehydration, clearing and Infiltration they embedded in 
resin  (Pro.  Sci.  Tech.  Au)  and  sectioned  using 
ultramicrotome  (Richert-Jung,  Au).  Semithin  section 
stained  with  toluidine  blue  and  studied  with  light 
microscope. The thin sections (80 nm thickness) were 
stained with  uranyl acetate  and lead  citrate and  were 
studied with Leo 906 transmission electron microscope 
(Leo, Germany). 
Results 
Light microscopy 
In  control  group,  Light  microscopy  revealed  that 
seminiferous tubules have a thick germinal epithelium 
and  their  lumina  contained  numerous  mature  sperms 
and interstitial spaces contained connective tissue and 
lydig cells (Figure 1A). 
The  spermatogenic  epitheliums  in  the  experimental  1 
group  compare  to  the  control  group  were  reduced  in 
thickness  and  in  some  tubules  germinal  epitheliums 
was destroyed (Figure 1B). The condition of germinal 
epithelium  in  experimental  2  group  was  similar  to 
control  group  and  detachment  between  spermatogenic 
cells were still present in few tubules (Figure 1C). 
 
 
Figure 1. Photomicrograph of a seminiferous tubule: A) from a 
control  mice  testis.  Note  the  regular  arrangement  of 
spermatogenic  cells.    B)  from  experimental  1  group  received 
cisplatin.  Note  tubular  destruction  and  their  depletion  from 
spermatogenic  cells.  C)  from  experimental  2  group  received 
both  cisplatin  and  GnRH  antagonist.  Note  relatively  complex 
recovery of spermatogenic epithelium. H & E staining.660 X.  
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Histomorphometric evaluation 
Histomorphometric  evaluation  of  seminiferous  tubules 
showed that the mean number of spermatogonia/ tubule 
in  control  group,  experimental  1  and  2  group  was 
43.22±1.55, 21.42 ±2.44 and 40.53±2.38 respectively. 
The  number  of  spermatogonia  was  significantly 
reduced  in  experimental  1  group  in  comparison  to 
control group (P<0.05) but the spermatogonial number 
in experimental 2  group was similar  to control  group 
(P>0.05) (Table  1). Thickness  of germinal  epithelium 
in control group was 57.33±4.1 µm but it decreased to 
20.90±3.84 µm in experimental 1 group and reached to 
50.09±4.08  µm  in  experimental  2  groups.  Statistical 
analysis  showed  that  the  difference  between  control 
and experimental 1 group was significant (P<0.05) but 
experimental  2  group  was  not  significant  (P>0.05) 
(Table 1).  
 
Table  1.  Comparison  of  different  parameters  in  testis  from 
three groups. 
Groups  No. of Spermatogonia 
cells/tubule 
Thickness of 
germinal Epi (µm) 
Control  43.22±1.55  57.33±4.1 
Cisplatin  21.42±2.44*  20.90±3.84* 
Cis+GnRH  40.53±2.38  50.09±4.08 
*: Significantly different from control group 
 
Electron microscopy  
EM study was specially focused on spermatogonia cells 
because these cells are germ cells and have prime role 
in normal spermatogenesis. 
Study  with  EM  in  control  group  showed  that  in  the 
seminiferous tubules the spermatogonia cells located on 
basal  lamina  and  had  oval  nuclei  (Figure  2A).  High 
magnification showed  some mitochondria  scattered  in 
the cytoplasm. The cells were tightly attached to each 
other or basal lamina (Figure 2B).  
There were also interstitial cells between seminiferous 
tubules  containing  secretory  granules  and  extensive 
smooth endoplasmic reticulum (Figure 2C). 
In  experimental  1  group,  spermatogenic  cells  were 
separated  from  each  other  or  basal  lamina  by  large 
spaces  (Figure  3A).  Spermatogenic  cells  had  several 
damaged organelles such as vacuolated mitochondria as 
well  (Figure  3B).  Furthermore  in  this  group 
intracellular  secretory  granules  were  dramatically 
increased in interstitial cells (Figure 3C). 
In experimental 2 group, the structure of tubules  was 
similar  to  control  group  but  in  some  tubules  small 
spaces were still present between spermatogenic cells.  
 
Discussion 
In the present study the protective role of cetrorelix on 
adverse  effects  induced  by  cisplatin  has  been 
investigated. The study revealed that in experimental 1 
group  which  received  only  cisplatin,  the thickness  of 
germinal epithelium and the number of spermatogonia 
in  somniferous  tubules  were  reduced  which  is 
considered  as  common  side  effect  of 
chemotherapy
3,4,20,21  and  or  indicates  that  cellular 
proliferation was reduced in the somniferous tubules. In 
accordance with our finding a reduction in mitosis and 
DNA  changes  has  been  reported  following  treatment 
with chemotherapic agents.
22,23 
 
 
Figure  2.  An  electronmicrograph  from  control  mice 
seminiferous  tubule:  A)  Spermatogonial  cells  (SP)  rested  on 
basal  lamina  (BL),  21560  X;    B)  Sertoli  cell    2784  X;  C) 
Interstitial cell 6000 X. Note: mitochondria (M), Blood - Testes - 
Barrier  (BTB),  secretory  granules  (SG)  and  smooth 
endoplasmic reticulum (SER). 
 
It  has  shown  that  alkilating  agents  that  are  used  in 
chemotherapy  affect  actively  dividing  cells  such  as 
spermatogonia and block their division.
2,3,24 
In  addition,  there  are  some  reports  showing  that 
anticancer  drugs  could  induce  apoptosis  in  germinal  
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epithelium.
1-10,25  Our  findings  such  as  mitochondrial 
vacuolization  are  evidence  of  apoptosis  in  germinal 
epithelium.  Other  changes,  such  as  separation  of 
spermatogenic  cells  from  each  other  could  also  be 
considered  as  preapoptotic  sign  which  supports 
hypothesis  that  cisplatin  as  a  chemotherapic  agent 
induces apoptosis on spermatogenic cells and cause to 
reduction of germinal epithelium. 
 
 
Figure  3.  A,  B:  An  electronmicrograph  from  seminiferous 
tubule  of  a  mouse  from  experimental  1  group;  A) 
Spermatogonial  cells  in  the  figure  are  separated  from  each 
other  by  a  large  space  (arrow).  2784  X  and  B)  Note, 
vacuolated  mithochondria  from  spermatogonial  cells  (M). 
12930  X,  C)  Electronmicrograph  showing  an  interstitial  cell 
from  testis  of  a  mice  experimental  1  group.  Note  numerous 
secretory granules in the cytoplasm. 1670 X. 
 
In  vitro  study  of  Newton  et  al  showed  that  cellular 
junction  mediated  by  cadherin  molecules;  result  in 
longevity of germ cells.
26 Cadherins are molecules that 
control the interaction between sertoli and germ  cells 
and  provide  vitality  of  germ  cells.  It  is  believed  that 
cadherin-  mediated  junctions  are  involved  in 
transmission  of  intercellular  signals  and  consequently 
in  differentiation  controls,  migration  and  vitality  of 
cells.
27,28  
In cisplatin treated mice, separation of cells from each 
other,  probably  deprive  cells  from  mitotic  factors 
secreted  by  adjacent  cells  and  cause  reduced  mitotic 
activity in spermatogenic cells. 
According  to  our  results,  intracellular  secretary 
granules  in  interstitial  cells  were  increased  in 
experimental 1 group. In this regard it is appears that, 
interstitial  cells  are  the  only  cells  that  have  LH 
receptors and in response to LH secretes estrogen and 
testosterone.  It  is  shown  that  levels  of  FSH  and  LH 
increases  following  chemotherapy.
3,25,29  Therefore  it 
can  be  concluded  that  the  increased  granules  in 
interstitial  cells  are  a  response  to  increased  LH 
following cisplatin treatment. 
In  experimental  2  group,  cetrorelix  relatively 
neutralized  the  adverse  effects  of  cisplatin  which 
indicates that cetrorelix has a protective effect against 
induced spermatogenesis toxicity of cisplatin. 
In  support  of  our  findings,  Udagawa  has  shown  that 
treatment  with  GnRH  analogs  improve 
spermatogenesis  recovery  following  chemotherapy
30 
and  Meistrich  et  al.  have  shown  that  following 
radiotherapy, the administration of GnRH agonists and 
antagonists  before  and  after  spermatogenesis  disorder 
have a protective effect.
19 
It is known that the secretion of FSH and LH increases 
after  chemotherapy  and  destruction  of  germinal 
epithelium.
30,31  Besides,  secretion  of  testosterone 
increases  after  exposure  to  reprotoxic  substance.
32 
Increased  testosterone  result  in  suppression  of 
membrane  bound  stem  cell  factor  (SCF)  expression 
which  is  necessary  for  spermatogenesis.
30  Thus  it 
appears  that  reduction  of  intratesticular  testosterone 
would  protect  spermatogenesis.  This  explains  the 
action  mechanisim  of  GnRH  antagonists,  i.e.  using 
GnRH antagonist before treatment leads to reduction of 
FSH, LH and testosterone. Consequently, reduction of 
these  hormones  suppresses  spermatogonial 
proliferation. Since non-dividing cells are less prone to 
toxic  effects  of  chemotherapeutic  agents, 
spermatogenic cells would not be affected during their 
non-proliferating  period.  In  agreement  with  this 
postulation,  Shetly  et  al.  have  demonstrated  that 
testosterone-therapy  following  radiotherapy,  will 
inhibit spermatogenesis improvement.
33 Meistrich et al 
also  demonstrated  that  with  reduction  of  testosterone 
can  improve  spermatogenesis  after  exposure  to 
reprotoxic substestrone.
34 
It  is  also  shown  that  in  rats  undergone  radiotherapy 
protocol elevation of FSH level result in inhibition of  
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spermatogonial  differentiation
  and  steradial  therapy 
following radiotherapy could improve spermatogenesis, 
after radio therapy, by suppressing the inhibitory effect 
of  testosterone.
33,35  Suppression  of  gonadotropins  and 
testosterone has also been demonstrated to improve the 
damaged spermatogenesis.
32 
Our results indicate that administration of cisplatin, as 
an anticancer drug in mice, destroys testicular germinal 
epithelium and  Administration  of  cetrorelix  prior  and 
along  with  chemotherapy  could  partially  protect 
germinal epithelium by acting on hypothalamic gonadal 
axis.  
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